The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes

Peer Review reports

Original Submission
13 Dec 2016	Submitted	Original manuscript
28 Feb 2017	Reviewed	Reviewer Report - Julien Paccou
22 Jun 2017	Reviewed	Reviewer Report - René Poggenborg
29 Jun 2017	Author responded	Author comments - Gabriele De Marco
Resubmission - Version 2
29 Jun 2017	Submitted	Manuscript version 2
4 Jul 2017	Author responded	Author comments - Gabriele De Marco
Resubmission - Version 3
4 Jul 2017	Submitted	Manuscript version 3
Publishing
5 Jul 2017	Editorially accepted
18 Jul 2017	Article published	10.1186/s12891-017-1659-1

Back to article page